Digital breast tomosynthesis cuts recall rates by 40 percent

May 3, 2012

Adding digital breast tomosynthesis to 2D mammography screening results in a 40% reduction in patient recall rates compared to routine screening mammography alone, a new study shows.

The study, conducted at Yale University School of Medicine in New Haven, CT, of 7,578 , found that the recall rate was 6.6% for digital breast tomosynthesis plus 2D screening mammography. It was 11.1% for 2D screening mammography alone, said Melissa Durand, MD, one of the authors of the study.

Similar recall rates were seen in both groups for masses, but the recall rate was significantly lower with digital breast tomosynthesis and 2D mammography compared to 2D mammography alone for asymmetries and calcifications, said Dr. Durand. The recall rate was 2.8% for asymmetries when both techniques were used compared to 7.1% for routine screening mammography, she said. "Tomosynthesis, which is 3D mammography, allows us to look at the breast in 1 mm slices. In routine mammography, is compressed and overlying tissue can look like a suspicious finding. Tomosynthesis resolves this by looking slice by slice," said Liane Philpotts, MD, a study author.

The for the combined examination is below the Food and Drug Administration limit for mammography and below the dose of film mammography, noted Dr. Durand. "For now we are doing both examinations, but it may not be long before we will be able to do just the tomosynthesis exam. Researchers are working on ways to get a 2D image out of the 3D data, and when that happens, there may be no need for the 2D examination," Dr. Philpotts said.

"Recalls from screening incite considerable anxiety in women. With digital breast tomosynthesis, we are seeing a dramatic reduction in our recall rates which helps lessen our patients' anxiety. Fewer recalls means fewer additional views, which is cost saving and may also reduce overall annual radiation dose," said Dr. Durand.

Explore further: Hospital gives first tomosynthesis mammograms in region this week

Related Stories

Hospital gives first tomosynthesis mammograms in region this week

December 7, 2011
There is still a one in eight lifetime risk that a woman will develop breast cancer, and the best tool against the disease remains early detection. Now, Women & infants Hospital of Rhode Island has taken the breast cancer ...

3D technology takes next step beyond traditional mammography

April 20, 2012
MILWAUKEE - After already having been through breast cancer treatment, Michelle Luckiesh did not think twice when doctors at Waukesha Memorial Hospital told her they had a new mammography device that may be able to detect ...

New technology offers the next generation of mammography

October 1, 2011
Breast cancer is the second most common type of cancer among women in the United States, with approximately 200,000 new diagnoses each year. Early detection is key in the treatment of breast cancer and the biggest advancement ...

Recommended for you

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.